Get started
Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

APDN trade ideas

APDN reverse split pumpThis is a corporate action where a company reduces the number of its outstanding shares and simultaneously increases the price of each share proportionally. For example, in a 1-for-10 reverse split, if you held 100 shares priced at $1 each, after the split, you would hold 10 shares priced at $10 each. The overall value of your holdings doesn’t change immediately because of the split, but the per-share market price increases. Companies might undertake a reverse split to boost their stock price and avoid being delisted from stock exchanges that have minimum share price requirements.
NASDAQ:APDNLong
by AntonioNaVi
Applied DNA Sciences bearish. APDNImpulse down with correlating indicators. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NASDAQ:APDNShort
by Rykin_Capital
$APDN entry PT 5.10-6 (ER next Thurs: 5/13/2021) PT 11-12 and hiApplied DNA Signs New Contract with U.S. Defense Logistics Agency Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
NASDAQ:APDNLong
by UnknownUnicorn19246015
FDA identifies "Assay Kit" able to detect SARS-CoV-2 mutationsU.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7) (FDA) published a safety communication (the "Communication") that identifies the Company’s Linea™ COVID-19 Assay Kit (the "Assay Kit") as one of only two tests marketed under the FDA’s Emergency Use Authorization (EUA) that are potentially able to identify certain SARS-CoV-2 mutations, including a mutation found in the U.K. variant of SARS-CoV-2 (B.1.1.7). According to recent publications, the B.1.1.7 variant has been identified within the United States and may be associated with an increased risk of transmission of the virus that causes COVID-19. Based on analysis conducted by the Company and FDA, one of the two S-gene targets (S1 and S2) of the Assay Kit has significantly reduced sensitivity in the presence of certain S-gene mutations, including a mutation found in the B.1.1.7 variant. finance.yahoo.com
NASDAQ:APDN
by AlenCiken
$APDN Upside targets for Applied DNAApplied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
NASDAQ:APDNLong
by DEXWireNews
1
Applied DNA Science Beats on earnings 10.1% to $4.25 in pre-market trading after the company reported better-than-expected Q1 earnings. Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
NASDAQ:APDNLong
by DEXWireNews
1
APDN has news and chatrooms are talking about it short $APDNSimple APDN has an ugly chart with some news that chatrooms are going to talk about like this will negate the chart. Shorting any meaningful pop is the best play be mindful you only need 1000 shares to get a decent return so base your risk on scaling in on that factor so you don't get too big too early and can ride this up into the roll over. Let the chatrooms move it before you dive in if they fail then it wasn't worth the short.
NASDAQ:APDNShort
by Osirustwits